These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 17262045)
1. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram. Potts AL; Young KL; Carter BS; Shenai JP J Perinatol; 2007 Feb; 27(2):120-2. PubMed ID: 17262045 [TBL] [Abstract][Full Text] [Related]
2. Neonatal morbidity due to maternal use of two antidepressant drugs. Jwa S; Wada Y; Yamamoto M; Sumida Y Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219 [No Abstract] [Full Text] [Related]
3. Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. Werremeyer A Am J Psychiatry; 2009 Nov; 166(11):1298. PubMed ID: 19884241 [No Abstract] [Full Text] [Related]
4. Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis? Treichel M; Schwendener Scholl K; Kessler U; Joeris A; Nelle M World J Pediatr; 2009 Feb; 5(1):65-7. PubMed ID: 19172337 [TBL] [Abstract][Full Text] [Related]
5. [The safety profile of escitalopram in pregnancy and breastfeeding]. Bellantuono C; Orsolini L; Bozzi F Riv Psichiatr; 2013; 48(6):407-14. PubMed ID: 24441517 [TBL] [Abstract][Full Text] [Related]
6. Citalopram and breast-feeding: serum concentration and side effects in the infant. Schmidt K; Olesen OV; Jensen PN Biol Psychiatry; 2000 Jan; 47(2):164-5. PubMed ID: 10664835 [TBL] [Abstract][Full Text] [Related]
7. Warning of risk to foetus for mothers using SSRIs. Kouros N Monash Bioeth Rev; 2013 Sep; 31(2):22-3. PubMed ID: 24844071 [No Abstract] [Full Text] [Related]
8. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040 [TBL] [Abstract][Full Text] [Related]
9. Use of escitalopram during pregnancy: navigating towards international guidelines and the real world. Gentile S Clin Drug Investig; 2008; 28(11):735-9. PubMed ID: 18840015 [TBL] [Abstract][Full Text] [Related]
11. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy. Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692 [TBL] [Abstract][Full Text] [Related]
12. Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution. Norton JD; Worley LL; Lowery CL Pediatrics; 2004 Dec; 114(6):1739-40; author reply 1740-1. PubMed ID: 15574649 [No Abstract] [Full Text] [Related]
13. Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy. Friedman EH Can J Psychiatry; 2001 May; 46(4):371. PubMed ID: 11387796 [No Abstract] [Full Text] [Related]
14. The effect of perinatal exposures on the infant: antidepressants and depression. Hanley GE; Oberlander TF Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223 [TBL] [Abstract][Full Text] [Related]
15. Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use. Kwon P; Lefkowitz W Pediatr Ann; 2008 Mar; 37(3):128-30. PubMed ID: 18411854 [No Abstract] [Full Text] [Related]
16. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study. Lin YT; Lu TS; Hansen RA; Wang CC Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037 [TBL] [Abstract][Full Text] [Related]